Controversial fertility expert Dr. Nayana Patel launches Zivia IVF clinic in Nairobi, reigniting Kenya’s surrogacy and reproductive health ethics debate.
In the leafy streets of Lavington, Nairobi, renowned Indian fertility specialist Dr. Nayana Patel has quietly launched a new IVF clinic under the Zivia IVF brand—reigniting long-simmering ethical concerns over reproductive medicine in Kenya.
Licensed by the Kenya Medical Practitioners and Dentists Council (KMPDC) in November 2024, the facility began operations in early 2025, offering in-vitro fertilization, surrogacy, and egg donation services—with procedures ranging from KES 800,000 to KES 1.2 million (USD 5,500–8,000).
“Kenya currently lacks a comprehensive law on surrogacy, which leaves us vulnerable,” warns Dr. Paul Omondi, a Nairobi-based reproductive health expert.
From Global Fame to Scrutiny
Dr. Patel holds an MBBS and MD in Obstetrics & Gynaecology from Gujarat University. She shot to international fame in 2004 after helping a 55-year-old woman deliver twins, making headlines across India and beyond.
Her original clinic—Akanksha Infertility Clinic in Anand, Gujarat—served over 1,600 surrogate cases by 2014, attracting clients from 30+ countries, including the UK, USA, Israel, and Australia.
But with success came scrutiny. International media like the BBC and The Guardian reported on conditions at the Anand clinic—describing surrogate mothers under surveillance and restrictions.
“These women were essentially locked in,” said Dr. Sheela Saravanan, a Germany-based public health researcher, after visiting in 2011.
Patel pushed back against the criticism.
“I am not selling babies—I am offering a solution to pain,” she told Al Jazeera in a 2013 documentary.
Internal Links You Might Like
- Surrogacy in Kenya: Legal gaps and future risks
- Medical tourism in Kenya
- Private hospitals expanding fertility services
- Regulating reproductive health in East Africa
Global Clients Speak, Critics Remain
While rights activists decried the Anand model as reproductive exploitation, some clients remain loyal to Patel.
“Yes, it’s unconventional, but it worked,” said Jane R., a French mother who used the clinic in 2015.
Even supporters like Dr. Peter Rosen, a New York-based reproductive endocrinologist, call for caution:
“She’s a visionary—but regulation must catch up. Medical ethics can’t be exported without checks.”
Kenyan Experts Raise the Alarm
In Nairobi, Patel’s arrival is polarizing. Some hail the investment as a boost to medical tourism and job creation. Others see a risk of bio-colonialism and exploitation in a country lacking proper laws.
“We have the science, but do we have the laws?” asks Dr. Wanjiru Ng’endo of Kenyatta National Hospital. “This should be a wake-up call to the Ministry of Health.”
“Without a legal framework, we risk becoming the next India circa 2012,” warns Anne Mbugua, head of the Reproductive Justice Coalition.
Will Zivia IVF Transform or Disrupt?
Zivia IVF plans to collaborate with private hospitals in Nairobi and Mombasa, building a regional fertility hub. Yet critics say unless Kenyan lawmakers draft clear surrogacy guidelines, the move may expose vulnerable women to reproductive exploitation.
As Dr. Patel framed it in a 2021 TEDx Talk:
“A womb has no passport. Parenthood should not be bound by borders.”
But in Kenya, where access to basic women’s healthcare remains patchy and reproductive rights deeply contested, her arrival is more than a business story—it’s a mirror to a country navigating complex ethical terrain.
